Ganglioside interactome toolkit
Ganglioside interactome toolkit
批准号:
9813609
负责人:
RONALD L SCHNAAR
金额:
$49.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2022-06-30
关键词:
AddressAlkynesAzidesBindingBinding ProteinsBiologyBiomedical ResearchBiotinCarrier ProteinsCell CommunicationCell Culture TechniquesCell membraneCell physiologyCell surfaceCellsCeramidesChargeChemicalsChemistryDiabetes MellitusDiazomethaneDiseaseEndocytosisGangliosidesGlycosphingolipidsGoalsHealthHumanHydrogen BondingIntegral Membrane ProteinIntellectual functioning disabilityIntracellular MembranesLaboratoriesLaboratory ResearchLinkLipidsMalignant NeoplasmsMediatingMethanolMethodsMinorityMolecularMyelin Associated GlycoproteinNerve DegenerationNervous system structureNeurodegenerative DisordersOutcomePlayPolysaccharidesProductionProteinsProteomeProteomicsProtocols documentationReagentResearch PersonnelRoleSialic AcidsSignal PathwaySignal TransductionSiteSpecificityStructureSurfaceSystemTechnologyTissuesValidationexperimental studyextracellularfluorophorefunctional grouphuman diseaseinterestmetabolomicstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Gangliosides, sialylated glycosphingolipids found on all vertebrate cells and tissues, play well-established
roles in diverse molecular signaling pathways that impact human diseases including diabetes, cancer, neuro-
degenerative proteinopathies, intellectual disability, and many others. The major ganglioside structures are
well-defined, finite, and shared across vertebrate species. Their glycans regulate cell signaling independent
of a protein carrier. Most gangliosides reside on the cell surface with their ceramide lipids embedded in the
plasma membrane and their glycans extending outward. They regulate cell physiology in two modes, cis and
trans. As cis regulators, they associate laterally via glycan binding to transmembrane proteins in the same
cell membrane to regulate their function. As trans recognition molecules they engage proteins in the
extracellular milieu or on apposing cells, mediating cell-cell interactions. Both cis and trans interactions are
specific for ganglioside glycan structures and essential for human health.
Most ganglioside functions and ganglioside-protein interactions remain poorly understood due to lack of
broadly accessible, adaptable and validated tools and optimized methods for their use. It is the goal of this
project to address this need using chemical biology technologies to synthesize a defined set of major
gangliosides carrying minimally disruptive bifunctional photoreactive and alkyne (click chemistry) tags.
Optimized and validated protocols will be generated to deliver bifunctionally tagged gangliosides to the outer
leaflet of the plasma membrane of cells, where most gangliosides reside and function. Our goal is to
synthesize the ganglioside probe toolkit, validate appropriate cell delivery of the probes, validate their use to
identify glycan-specific ganglioside binding proteins, and transfer the reagents and protocols to other
biomedical research laboratories within the term of this project. The deliverables, ganglioside probes and
validated methods for their use, will be distributed broadly to biomedical researchers to discover the identities,
specificities, distributions and functions of ganglioside binding proteins relevant to a variety of human cells,
tissues, and diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ganglioside interactome toolkit
-
批准号:10163818
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2019
-
负责人:RONALD L SCHNAAR
-
依托单位:
Human siglec ligands control mast cell and eosinophil mediated inflammation
-
批准号:10331727
-
项目类别:
-
资助金额:$46.38万
-
财政年份:2018
-
负责人:RONALD L SCHNAAR
-
依托单位:
Human siglec ligands control mast cell and eosinophil mediated inflammation
-
批准号:10097998
-
项目类别:
-
资助金额:$51.0万
-
财政年份:2018
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8289349
-
项目类别:
-
资助金额:$220.75万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:9277536
-
项目类别:
-
资助金额:$223.62万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8072323
-
项目类别:
-
资助金额:$231.17万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8722274
-
项目类别:
-
资助金额:$4.64万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8477244
-
项目类别:
-
资助金额:$205.87万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8669096
-
项目类别:
-
资助金额:$214.16万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:8018568
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:7767664
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:7873111
-
项目类别:
-
资助金额:$9.53万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:7577517
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:8214620
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:7461889
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Enhancing axon regeneration by multi-inhibitor blocking
-
批准号:6895160
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2004
-
负责人:RONALD L SCHNAAR
-
依托单位:
Enhancing axon regeneration by multi-inhibitor blocking
-
批准号:6770878
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2004
-
负责人:RONALD L SCHNAAR
-
依托单位:
Pharmacology Training Grant
-
批准号:6894128
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2000
-
负责人:RONALD L SCHNAAR
-
依托单位:
PHARMACOLOGY TRAINING GRANT
-
批准号:6628729
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2000
-
负责人:RONALD L SCHNAAR
-
依托单位:
PHARMACOLOGY TRAINING GRANT
-
批准号:6498520
-
项目类别:
-
资助金额:$27.7万
-
财政年份:2000
-
负责人:RONALD L SCHNAAR
-
依托单位:
海外基金